JP2024516679A5 - - Google Patents

Info

Publication number
JP2024516679A5
JP2024516679A5 JP2023566808A JP2023566808A JP2024516679A5 JP 2024516679 A5 JP2024516679 A5 JP 2024516679A5 JP 2023566808 A JP2023566808 A JP 2023566808A JP 2023566808 A JP2023566808 A JP 2023566808A JP 2024516679 A5 JP2024516679 A5 JP 2024516679A5
Authority
JP
Japan
Prior art keywords
biomarker
subject
amount
pct
suspected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023566808A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024516679A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/061553 external-priority patent/WO2022229422A2/en
Publication of JP2024516679A publication Critical patent/JP2024516679A/ja
Publication of JP2024516679A5 publication Critical patent/JP2024516679A5/ja
Pending legal-status Critical Current

Links

JP2023566808A 2021-04-30 2022-04-29 敗血症の早期検出用のigfbp7マーカーパネル Pending JP2024516679A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21171492 2021-04-30
EP21171492.8 2021-04-30
PCT/EP2022/061553 WO2022229422A2 (en) 2021-04-30 2022-04-29 Igfbp7 marker panels for early detection of sepsis

Publications (2)

Publication Number Publication Date
JP2024516679A JP2024516679A (ja) 2024-04-16
JP2024516679A5 true JP2024516679A5 (https=) 2025-04-24

Family

ID=75746434

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023566808A Pending JP2024516679A (ja) 2021-04-30 2022-04-29 敗血症の早期検出用のigfbp7マーカーパネル

Country Status (5)

Country Link
US (1) US20240219404A1 (https=)
EP (1) EP4330681A2 (https=)
JP (1) JP2024516679A (https=)
CN (1) CN117242349A (https=)
WO (1) WO2022229422A2 (https=)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2476597C (en) 2002-02-28 2011-05-17 Metanomics Gmbh & Co. Kgaa Mass spectrometry method for analysing mixtures of substances
US20090197794A1 (en) 2005-07-13 2009-08-06 Aird William C Methods of Diagnosing and Treating an Inflammatory Response
CN103123359B (zh) 2007-08-03 2015-07-29 B.R.A.H.M.S有限公司 降钙素原(pct)在患原发性非传染疾病的患者的风险分级和预后中的应用
JP5722587B2 (ja) 2009-10-13 2015-05-20 ベー.エル.アー.ハー.エム.エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 急性脳卒中または一過性脳虚血発作を有する患者における細菌感染の診断のためのプロカルシトニン及び抗生物質治療のガイダンス
JP5763098B2 (ja) * 2009-12-20 2015-08-12 アスチュート メディカル,インコーポレイテッド 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
JP2012159356A (ja) * 2011-01-31 2012-08-23 Mochida Pharmaceut Co Ltd 敗血症診断用組合せマーカー
RU2016112915A (ru) 2013-09-05 2017-10-09 Эф-Ай-Оу Корпорейшн Биомаркеры для раннего выявления критической или угрожающей жизни ответной реакции на заболевание и/или ответной реакции на лечение
JP6859334B2 (ja) * 2015-10-08 2021-04-14 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 手術前に測定した際にakiのリスクを予測するためのigfbp7
WO2018208684A1 (en) * 2017-05-07 2018-11-15 Astute Medical, Inc. Use of insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2 in the management of renal replacement therapy

Similar Documents

Publication Publication Date Title
Kamath et al. A model to predict survival in patients with end‐stage liver disease
JP6595984B2 (ja) 腎機能に関連付けられるバイオマーカーおよびそれを使用する方法
Fung et al. A biomarker panel for peripheral arterial disease
CN101568837A (zh) 用于预测血管事件和诊断急性冠状动脉综合征的方法
Makaryus et al. Falsely elevated cardiac troponin I levels
JP2024516678A5 (https=)
JP2024516680A5 (https=)
JP2024516677A5 (https=)
JP2024516679A5 (https=)
RU2754776C1 (ru) Способ клинико-лабораторного прогнозирования тяжести covid-19
WO2003039349A2 (en) Method of using physiological markers to estimate cardiovascular risk
JP2024515086A5 (https=)
JP2024516681A5 (https=)
JP2024516001A5 (https=)
CN115586342B (zh) 血清可溶性st2在制备预测主动脉夹层患者预后产品中的应用及相关预测装置
JP2024537774A5 (https=)
WO2024154832A1 (ja) 全身性強皮症の検出方法
JP2024516665A5 (https=)
JP6727660B2 (ja) 糖尿病性腎症の判定マーカー
Zanfaly et al. Heparin-binding protein as a predictive and diagnostic biomarker for severe sepsis and septic shock in patients with sepsis
Ringdahl et al. False-positive troponin I in a young healthy woman with chest pain.
JP7510649B2 (ja) 心不全マーカー
Kumar et al. Variation in biochemical parameters in COVID-19 patients admitted at a tertiary care dedicated COVID hospital: a prospective study
Buggy et al. Microalbuminuria and coronary heart disease in non-diabetics
RU2825710C2 (ru) Способ прогнозирования летального исхода у пациентов с цитокиновым штормом, ассоциированным с COVID-19